Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: XenaLives who wrote (26)	2/23/2001 11:36:44 AM
From: Jibacoa	Respond to of 544

Paula: NEOT: Has in its favor the 51% insiders holding and the fact that there has been additional recent buying by insiders. The short position at 19.7% of the float is also probably a + since they will have to cover some day.<g> Of course not delving into Neurotrofin's potential. <g> From a TA point of view, it did pretty well after the buy signal on Jan.31 with volume above 2 million for the day. Now it has to deal with the resistance at the 5 to 5 1/6 level from the intra-day Hs on Feb.8 and Feb.21. It seems to have good support at the 3 1/4 level. By the way NUTX is over the Jan., Dec., Oct. and Nov. Hs and seems it will test last year's March H. Bernard

To: XenaLives who wrote (26)	2/23/2001 11:52:11 AM
From: Jibacoa	Read Replies (1) \| Respond to of 544

IMGN: Remains on a down trend. It may find support at the 11 level. Will be some time before we know if the deals with Genzyme Transgenics and Avalon bear any fruit. Today it is trying to reverse the early dip to 13 3/4 and the volume on the second 1/2 hour of trading (139,500) which brought the price back above the 14 level, was slightly higher than the down volume on the first half hour (128,800) It could find support at the 14 level (from the double bottom on Jan 8 & Jan, 10 at this level), but as I mentioned, seems to have better support at the 11 level. At any rate I would not consider buying until it is able to resume an uptrend. RAGL Bernard